微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 36.3% | 3.71% | -3.87% | 101/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 37.76% | 1.03% | 6.07% | 94/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 35.6% | 1.52% | 0.05% | 99/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 35.59% | -1.85% | 1.67% | 99/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 35% | -4.37% | -6.35% | 103/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 37.38% | 2.52% | 6.57% | 97/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 35.07% | 13.37% | -3.27% | 105/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 36.26% | 18.6% | -0.95% | 100/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 36.61% | 29.18% | 0.4% | 105/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 36.46% | 35.78% | 17.85% | 97/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 30.94% | 30.56% | 1.2% | 112/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 30.57% | 32.48% | 7.89% | 107/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 28.34% | 23.27% | 5.53% | 111/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 26.85% | 4.78% | 13.32% | 108/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 23.7% | 27.78% | 2.68% | 118/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 23.08% | 27.29% | 0.39% | 111/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 22.99% | 28.7% | -10.3% | 116/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 25.63% | 28.57% | 38.19% | 103/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 18.54% | -25.86% | 2.29% | 124/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 18.13% | -27.37% | 1.5% | 106/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 17.86% | -28.12% | -10.39% | 116/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 19.93% | -19.1% | -20.3% | 95/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 25.01% | 3.04% | 0.2% | 122/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 24.96% | 3.45% | 0.45% | 86/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 24.85% | -2.7% | 0.86% | 107/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 24.64% | 2.43% | 1.5% | 75/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 24.27% | -6.33% | 0.6% | 111/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 24.13% | -4.29% | -5.52% | 62/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 25.54% | 4.74% | 6.18% | 70/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 24.05% | -4.8% | -7.18% | 53/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 25.91% | -4.24% | 2.78% | 106/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 25.21% | -2.89% | 3.4% | 52/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 24.38% | -7.45% | -3.49% | 58/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 25.27% | -11.03% | -6.63% | 50/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 27.06% | -18.11% | 4.23% | 98/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 25.96% | 2% | -1.46% | 45/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 26.35% | -18.7% | -7.23% | 55/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 28.4% | 1.37% | -14.06% | 42/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 33.05% | 22.29% | 1.97% | 69/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-06-30 | 32.41% | 19.5% | 19.93% | 44/141 | 52.6% | 健帆生物 | 84.23% | 行业排名> |